Long-term consequences on growth and development |
Balance of energy intake and energy expenditure modulate critical growth hormones such as GH and IGF-1. The appetite suppressant, anti-hedonic, and fatigue effects of the GLP-1RA may alter this balance during critical periods of growth and development. |
Abuse among patients with diagnosed eating disorders |
Pediatric-aged patients (male and female) with eating disorders are known to abuse appetite suppressants. |
Abuse among children and adolescents in certain competitive sports (e.g., wrestling, martial arts, gymnastics, ballet) |
Children and adolescents involved in school, club, or community sports like wrestling or gymnastics where body weight is a competitive factor are known to engage in unhealthy behaviors to accelerate weight loss. |
Unsupervised use for unwarranted self-perception of obesity and overweight, particularly among female adolescents |
Inaccurate perception of being overweight in healthy-weight adolescents result in unnecessary weight control behaviors [29]. In children and young adults, supplements sold for weight loss, muscle building, and energy were associated with almost three times the risk for severe medical outcomes compared with vitamins [30]. |
Excessive or insufficient medical prescription in populations with high prevalence of obesity and poor fitness |
Pediatricians have little or no formal training in effective ways to deal with obesity, overweight, or poor physical fitness in their patients. Short-term effectiveness and convenience of drug prescriptions may be well intended but lead to untested effects when used for longer duration during critical periods of growth and development. |
Distorted cost-benefit relationship of long-term use in youth |
Result in disparities in GLP-1RA availability
Promote counterfeit or drug diversion activity.
Off-label utilization may not be covered by insurers.
Possible lifelong therapy may be cost-prohibitive.
|